Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Tissue Biobank for People at Genetic Risk for Aggressive Disease

NCT06659614 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT06659614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06659614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Tissue Biobank for People at Genetic Risk for Aggressive Disease
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
January 31, 2034
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition, prostate cancer